ReadiVet Joins BlueSky At-Home Veterinary Care to Expand Convenient In-Home Vet Care

KENNEBUNK, Maine, June 5, 2026 /PRNewswire/ — ReadiVet is merging with BlueSky At-Home Veterinary Care to…

The Inner Circle acknowledges Aashish Valvani, MD acknowledged as a Pinnacle Lifetime Member

FLINT, Mich., June 5, 2026 /PRNewswire/ — Prominently featured in The Inner Circle,Aashish Valvani, MD is…

Greenberg Traurig Expands Health Care & FDA Capabilities in California with Addition of Deborah J. Rotenberg and Team

SACRAMENTO, Calif., June 5, 2026 /PRNewswire/ –Global law firm Greenberg Traurig, LLP continues the growth of…

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC,…

Grifols Supports AlphaDetect to Accelerate Detection of Alpha-1

The sponsorship will help expand proven strategies to consistently detect a genetic, irreversible, and progressive condition…

Quantinuum Announces Closing of Upsized Initial Public Offering

BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing…

Food Safety Testing Market Expected to Reach $44.1 Billion by 2033, at a CAGR of 7% : Allied Market Research

Driven by intensifying food safety requirements with the increased stringency of regulatory guidelines, a substantial and…

Brayton Purcell LLP destaca los informes de KQED sobre el proyecto de ley federal que afecta las reclamaciones de silicosis por piedras artificiales

NOVATO, California, 5 de junio de 2026 /PRNewswire-HISPANIC PR WIRE/ — Brayton PurcellLLP está llamando la…

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin…

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and…